UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective

Lancet neurology, 2007-04, Vol.6 (4), p.340-351

Ferner, Rosalie E, Dr

2007

Volltextzugriff (PDF)

Optic pathway gliomas in neurofibromatosis-1: Controversies and recommendations

Annals of neurology, 2007-03, Vol.61 (3), p.189-198

2007

Volltextzugriff (PDF)

The characteristics of 76 atypical neurofibromas as precursors to neurofibromatosis 1 associated malignant peripheral nerve sheath tumors

Neuro-oncology (Charlottesville, Va.), 2018-05, Vol.20 (6), p.818-825

2018

Volltextzugriff (PDF)

Neurofibromatosis Type 1-Associated MPNST State of the Science: Outlining a Research Agenda for the Future

JNCI : Journal of the National Cancer Institute, 2017-08, Vol.109 (8)

2017

Volltextzugriff (PDF)

The neurofibromatoses

Practical Neurology, 2010-04, Vol.10 (2), p.82-93

Ferner, Rosalie E

2010

Volltextzugriff (PDF)

Toxicity profile of bevacizumab in the UK Neurofibromatosis type 2 cohort

Journal of neuro-oncology, 2017-01, Vol.131 (1), p.117-124

2017

Volltextzugriff (PDF)

Association of sociodemographic and clinical factors with the quality of life of Brazilian individuals with Neurofibromatosis type 1: a cross-sectional study

Anais brasileiros de dermatología, 2024-07, Vol.99 (4), p.520-526

2024

Volltextzugriff (PDF)

Array-Based Comparative Genomic Hybridization Identifies CDK4 and FOXM1 Alterations as Independent Predictors of Survival in Malignant Peripheral Nerve Sheath Tumor

Clinical cancer research, 2011-04, Vol.17 (7), p.1924-1934

2011

Volltextzugriff (PDF)

High-Resolution DNA Copy Number Profiling of Malignant Peripheral Nerve Sheath Tumors Using Targeted Microarray-Based Comparative Genomic Hybridization

Clinical cancer research, 2008-02, Vol.14 (4), p.1015-1024

2008

Volltextzugriff (PDF)

Hearing and facial function outcomes for neurofibromatosis 2 clinical trials

Neurology, 2013-11, Vol.81 (21 Suppl 1), p.S25

2013

Volltextzugriff (PDF)

Frequency of SMARCB1 mutations in familial and sporadic schwannomatosis

Neurogenetics, 2012-05, Vol.13 (2), p.141-145

2012

Volltextzugriff (PDF)

Neurofibromatosis type 1

Nature reviews. Disease primers, 2017-02, Vol.3 (1), p.17004-17004, Article 17004

2017

Volltextzugriff (PDF)

Bevacizumab in neurofibromatosis type 2 (NF2) related vestibular schwannomas: a nationally coordinated approach to delivery and prospective evaluation

Neuro-oncology practice, 2016-12, Vol.3 (4), p.281-289

2016

Volltextzugriff (PDF)

Neurofibromatosis type 1 (NF1): diagnosis and management

Handbook of clinical neurology, 2013, Vol.115, p.939-955

2013

Volltextzugriff (PDF)

Neurofibromatosis 1

European journal of human genetics : EJHG, 2007-02, Vol.15 (2), p.131-138

FERNER, Rosalie E

2007

Volltextzugriff (PDF)

Clinical presentation and prognostic indicators in 100 adults and children with neurofibromatosis 1 associated non-optic pathway brain gliomas

Journal of neuro-oncology, 2017-07, Vol.133 (3), p.609-614

2017

Volltextzugriff (PDF)

The effect of post-injection 18F-FDG PET scanning time on texture analysis of peripheral nerve sheath tumours in neurofibromatosis-1

EJNMMI research, 2017-04, Vol.7 (1), p.35-35, Article 35

2017

Volltextzugriff (PDF)

Neurofibromatosis-related tumors: emerging biology and therapies

Current opinion in pediatrics, 2015-02, Vol.27 (1), p.26-33

2015

Volltextzugriff (PDF)

Evaluation of quality of life in adults with neurofibromatosis 1 (NF1) using the Impact of NF1 on Quality Of Life (INF1-QOL) questionnaire

Health and quality of life outcomes, 2017-02, Vol.15 (1), p.34-34, Article 34

2017

Volltextzugriff (PDF)

Guidelines for the diagnosis and management of individuals with neurofibromatosis 1

Journal of Medical Genetics, 2007-02, Vol.44 (2), p.81-88

2007

Volltextzugriff (PDF)

Management of neurofibromatosis type 1-associated plexiform neurofibromas

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (11), p.1827-1844

2022

Volltextzugriff (PDF)

Neurovascular complications in adults with Neurofibromatosis type 1: A national referral center experience

American journal of medical genetics. Part A, 2022-10, Vol.188 (10), p.3009-3015

2022

Volltextzugriff (PDF)

Reliability of functional outcome measures in adults with neurofibromatosis 1

SAGE open medicine, 2018, Vol.6, p.2050312118786860-2050312118786860

2018

Volltextzugriff (PDF)

ERN GENTURIS clinical practice guidelines for the diagnosis, treatment, management and surveillance of people with schwannomatosis

European journal of human genetics : EJHG, 2022-07, Vol.30 (7), p.812-817

2022

Volltextzugriff (PDF)

Functional outcome measures for NF1-associated optic pathway glioma clinical trials

Neurology, 2013-11, Vol.81 (21 Suppl 1), p.S15

2013

Volltextzugriff (PDF)

1 – 25 von 79

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(72)
Mit Volltextzugriff
(69)

Publikationsform

Sprache

Englisch
(79)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(59)
Science & Technology
(59)
Humans
(51)
Clinical Neurology
(23)
Genetics & Heredity
(23)
Tumors
(23)
Neurosciences & Neurology
(22)
Child
(20)
Neurology
(19)
Adult
(18)
Male
(18)
Female
(17)
Neurofibromatosis
(17)
Neurofibromatosis 1 - Complications
(17)
Adolescent
(16)
Biological And Medical Sciences
(14)
Middle Aged
(14)
Oncology
(14)
Medical Sciences
(13)
Neurofibromatosis 1 - Diagnosis
(13)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective

Optic pathway gliomas in neurofibromatosis-1: Controversies and recommendations

The characteristics of 76 atypical neurofibromas as precursors to neurofibromatosis 1 associated malignant peripheral nerve sheath tumors

Neurofibromatosis Type 1-Associated MPNST State of the Science: Outlining a Research Agenda for the Future

The neurofibromatoses

Toxicity profile of bevacizumab in the UK Neurofibromatosis type 2 cohort

Association of sociodemographic and clinical factors with the quality of life of Brazilian individuals with Neurofibromatosis type 1: a cross-sectional study

Array-Based Comparative Genomic Hybridization Identifies CDK4 and FOXM1 Alterations as Independent Predictors of Survival in Malignant Peripheral Nerve Sheath Tumor

High-Resolution DNA Copy Number Profiling of Malignant Peripheral Nerve Sheath Tumors Using Targeted Microarray-Based Comparative Genomic Hybridization

Hearing and facial function outcomes for neurofibromatosis 2 clinical trials

Frequency of SMARCB1 mutations in familial and sporadic schwannomatosis

Neurofibromatosis type 1

Bevacizumab in neurofibromatosis type 2 (NF2) related vestibular schwannomas: a nationally coordinated approach to delivery and prospective evaluation

Neurofibromatosis type 1 (NF1): diagnosis and management

Neurofibromatosis 1

Clinical presentation and prognostic indicators in 100 adults and children with neurofibromatosis 1 associated non-optic pathway brain gliomas

The effect of post-injection 18F-FDG PET scanning time on texture analysis of peripheral nerve sheath tumours in neurofibromatosis-1

Neurofibromatosis-related tumors: emerging biology and therapies

Evaluation of quality of life in adults with neurofibromatosis 1 (NF1) using the Impact of NF1 on Quality Of Life (INF1-QOL) questionnaire

Guidelines for the diagnosis and management of individuals with neurofibromatosis 1

Management of neurofibromatosis type 1-associated plexiform neurofibromas

Neurovascular complications in adults with Neurofibromatosis type 1: A national referral center experience

Reliability of functional outcome measures in adults with neurofibromatosis 1

ERN GENTURIS clinical practice guidelines for the diagnosis, treatment, management and surveillance of people with schwannomatosis

Functional outcome measures for NF1-associated optic pathway glioma clinical trials

Suchergebnisse filtern